$KIDS

Pritzker Jennifer N. sold $6.4M of KIDS (indirect holdings)

Pritzker Jennifer N. sold 302,369 indirectly-held shares of ORTHOPEDIATRICS CORP (KIDS) at $21.01 ($6.35M total) on 2026-09-10.

Original reporting
SEC EDGAR · Pritzker Jennifer N.
Published Sep 11, 2026, 12:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 1:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KIDS
Bearish
medium confidence
Mentioned
$KIDS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KIDSBearishLow
01

Why it matters

The sale reduces insider ownership but does not change company fundamentals.

02

Market read

Routine insider sale with modest size; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs.

Relevance 6/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider transactions; investors monitor for signals.

Company-level read

Ticker impact

$KIDSBearishMedium confidence
Context

SEC Form 4 shows insider Jennifer N. Pritzker sold 302,369 shares of Orthopedics Corp for $6.35M.

Expected impact

Potential short-term pressure on KIDS price.

Evidence & confidence

Sale represents ~5% of remaining holdings; market may view as a red flag.

Market effects

Minimal impact on orthopedics sector.

None

None

Counterpoint

Insider may be diversifying; sale does not imply company weakness.

Key entities

  • Jennifer N. Pritzker

    10% owner of Orthopedics Corp.

  • Orthopedics Corp

    Medical device manufacturer trading under ticker KIDS.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KIDSHighAI 8/10

OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher

OrthoPediatrics (KIDS) reported Q2 revenue of $70.5M, up 15% YoY, and raised 2026 guidance to $265M-$269M. Trauma and Deformity revenue grew 26%, while international sales rose 22%. Despite higher expenses, gross margin expanded to 74% and adjusted EBITDA doubled to $6.8M. Net loss remained at $7.2M, and cash reserves declined to $47.9M.

$KIDSMed

OrthoPediatrics Corp. Q2 2026 Earnings Call Summary

OrthoPediatrics reported Q2 2026 progress toward a “financial inflection point,” citing record adjusted EBITDA margins near 10% and a shift toward positive free cash flow. Trauma and Deformity revenue grew 26% on implant share gains and early 3P Hip deployments. Management expects positive free cash flow in H2 2026 and FCF break-even or better for full-year 2026, with conservative timing assumptions for capital placements and international orders.